Media Release: Tuesday 28 June 2016
The Research Australia Health & Medical Research Awards: Nominations open for fresh faces, experienced hands and every health and medical researcher in between
Applications opened today for the Research Australia Awards, recognising contributions in everything from cutting edge research through to advocacy, and philanthropic work.
In a field dedicated to improving the lives of Australians, the Research Australia Awards are an opportunity to celebrate those who make life-changing advances possible.
“There are so many extraordinary people in this sector who are deserving of recognition, and we are calling for them to nominate themselves and their colleagues,” said CEO of Research Australia, Nadia Levin.
“The Awards are the health and medical research industry’s night of nights – they are the opportunity for the best and brightest in the industry to recognise each other’s achievements.
Continue reading “Research Australia Health & Medical Research Awards Nominations Now Open!”
Media Release: Monday 27 June 2016
An alliance of 160 health and medical research organisations has warned that without a multi-party commitment, the ground-breaking Medical Research Future Fund risks being dead on arrival.
“When medical researchers, albeit half-jokingly, talk of leaving their labs and taking to the streets, you know something has gone awry with public policy,” said Research Australia CEO, Nadia Levin.
Continue reading “Medical Research Future Fund at Risk Without Multi-Party Commitment”
36th year of prestigious $80,000 research grant
Nominations for GSK’s Award for Research Excellence (ARE) are now open until 4 July. The longstanding award seeks to assist Australian research heroes by providing the winner with an $80,000 grant to support their research journey.
The GSK Award for Research Excellence is one of the most prestigious available to the Australian medical research community. It has been awarded since 1980 to recognise outstanding achievements in medical research and facilities career development with potential importance to human health and Australian research.
Continue reading “GSK Award for Research Excellence open for nominations”
Media Release: Monday 6 June, 2016
A new report from the health and medical sector says the Medical Research Future Fund (MRFF) needs to prioritise closing gaps between health research, health practice and the health economy.
Translating Research for a sustainable future comprehensively brings together the positions of 160 of Australia’s leading health and medical research organisations, companies and personnel.
The review, contributed to by prominent researchers, universities, and businesses in the field, outlines the sector’s view on priorities for the MRFF over the next two and five years.
Continue reading “New expert report to guide Medical Research Future Fund”
Media Release: Wednesday 11 May 2016
Decades’ worth of highly-specialised experience is being added to the leadership of Research Australia, with the appointment of a new CEO and four new Board members.
Research Australia is an alliance of 160 members and supporters advocating for health and medical research in Australia.
Continue reading “New Leaders to Strengthen the Alliance of Australian Health and Medical Researchers”
Media Release: Friday 20 May 2016
A clinical trial investigating reducing risk of neonatal infections related to pre-labour ruptured membranes, has been awarded the inaugural Trial of the Year Award 2016 by the Australian Clinical Trials Alliance (ACTA).
Professor Johnathan Morris, chief investigator, this morning accepted the award on behalf of the trial investigators at the Clinical Trials 2016 Breakfast and Award Ceremony this morning from Health Minister Sussan Ley.
Continue reading “Australian take on International Clinical Trials Day”
Research Australia Member Webinar: MRFF Strategies and Priorities – responding to the consultation
The MRFF provides a unique opportunity to transform Australian health and medical research and innovation.
The Health Minister has appointed an Advisory Board of eminent Australians to develop a five-year Strategy for the MRFF and the funding priorities for the first two years.
Continue reading “Medical Research Future Fund Strategies and Priorities – responding to the consultation”
The Australian Medical Research Advisory Board supporting the Medical Research Future Fund (MRFF) has announced the commencement of a two stage consultation process on the five-year Strategy and two-year Priorities. The first stage is a public call for submissions.
A consultation Paper and more information in relation to making a submission are available on the Department of Health website. Submissions close on 6 June 2016. This will be followed by a second stage of targeted consultations to be held in July.
Continue reading “Medical Research Future Fund consultations commence”
Media Release: Tuesday 3 May 2016
Recently the University of Sydney officially opened the Australian Institute for Nanoscale Science and Technology.
Nadia Levin is CEO of Research Australia, the peak group representing 160 members advocating for health and medical research in Australia. In response to requests for comment, she said:
“In 1965, Intel co-founder Gordon Moore correctly predicted exponential growth in computing technology, with computer power to double in capacity, and halve in price, every two years.
“Common computers since that time have gone from the size of houses to rooms to watches and beyond, and their capabilities today are at levels considered sci-fi even at the turn of this century.
Continue reading “Nanoscience Facility is a $150M Investment in Australian Ingenuity”
Media Release: Wednesday 4 May 2016
Research Australia, which represents 160 health and medical research organisations, has described last night’s budget as mixed bag – with some wins, some losses and some more detail required.
“The Federal Government is making all of the right noises when it comes to innovation, health and research, and it is pleasing that they remain on the agenda,” said CEO Nadia Levin.
“The budget would be described by my members as a combination of ‘treatments, placebos and nocebos’, and the challenge for government is to back it up with funding.”
Continue reading “Federal Budget a Combination of Treatments, Placebos and Nocebos for Health and Medical Research”